384 related articles for article (PubMed ID: 25692868)
1. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
Mazzotta E; Ursini T; Agostinone A; Di Nicola AD; Polilli E; Sozio F; Vadini F; Pieri A; Trave F; De Francesco V; Capasso L; Borderi M; Manzoli L; Viale P; Parruti G
AIDS Patient Care STDS; 2015 Apr; 29(4):169-80. PubMed ID: 25692868
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men.
Paccou J; Viget N; Drumez E; Cortet B; Robineau O
Med Mal Infect; 2018 Oct; 48(7):442-448. PubMed ID: 29699830
[TBL] [Abstract][Full Text] [Related]
3. Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors.
Tsai MS; Hung CC; Liu WC; Chen KL; Chen MY; Hsieh SM; Sheng WH; Sun HY; Shih TT
J Microbiol Immunol Infect; 2014 Apr; 47(2):109-15. PubMed ID: 23073318
[TBL] [Abstract][Full Text] [Related]
4. Low bone mass prevalence, therapy type, and clinical risk factors in an HIV-infected Brazilian population.
Pinto Neto LF; Ragi-Eis S; Vieira NF; Soprani M; Neves MB; Ribeiro-Rodrigues R; Miranda AE
J Clin Densitom; 2011; 14(4):434-9. PubMed ID: 22051092
[TBL] [Abstract][Full Text] [Related]
5. Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.
Assoumou L; Katlama C; Viard JP; Bentata M; Simon A; Roux C; Kolta S; Costagliola D; Rozenberg S;
AIDS; 2013 Sep; 27(15):2425-30. PubMed ID: 24029735
[TBL] [Abstract][Full Text] [Related]
6. [Influence of long-term highly active antiretroviral therapy on bone mineral density in HIV/AIDS patients].
Su YB; Xie J; Han Y; Qiu ZF; Li YL; Song XJ; Yu W; Li TS
Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1155-8. PubMed ID: 22883000
[TBL] [Abstract][Full Text] [Related]
7. Antiepileptic drugs and high prevalence of low bone mineral density in a group of inpatients with chronic epilepsy.
Beerhorst K; Tan IY; De Krom M; Verschuure P; Aldenkamp AP
Acta Neurol Scand; 2013 Oct; 128(4):273-80. PubMed ID: 23461582
[TBL] [Abstract][Full Text] [Related]
8. Screening for osteoporosis in anorexia nervosa: prevalence and predictors of reduced bone mineral density.
Winston AP; Alwazeer AE; Bankart MJ
Int J Eat Disord; 2008 Apr; 41(3):284-7. PubMed ID: 18176948
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.
Puthanakit T; Saksawad R; Bunupuradah T; Wittawatmongkol O; Chuanjaroen T; Ubolyam S; Chaiwatanarat T; Nakavachara P; Maleesatharn A; Chokephaibulkit K
J Acquir Immune Defic Syndr; 2012 Dec; 61(4):477-83. PubMed ID: 22918157
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
Carr A; Grund B; Neuhaus J; Schwartz A; Bernardino JI; White D; Badel-Faesen S; Avihingsanon A; Ensrud K; Hoy J;
HIV Med; 2015 Apr; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332
[TBL] [Abstract][Full Text] [Related]
11. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
[TBL] [Abstract][Full Text] [Related]
12. Low bone mineral density in HIV-positive young Italians and migrants.
Cascio A; Colomba C; Di Carlo P; Serra N; Lo Re G; Gambino A; Lo Casto A; Guglielmi G; Veronese N; Lagalla R; Sergi C
PLoS One; 2020; 15(9):e0237984. PubMed ID: 32881882
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with low bone mineral density in a Brazilian cohort of vertically HIV-infected adolescents.
Schtscherbyna A; Pinheiro MF; Mendonça LM; Gouveia C; Luiz RR; Machado ES; Farias ML
Int J Infect Dis; 2012 Dec; 16(12):e872-8. PubMed ID: 23031418
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of bone mineral density abnormalities and related risk factors in an ambulatory HIV clinic population.
Guillemi S; Harris M; Bondy GP; Ng F; Zhang W; Lima VD; Michaels CE; Belzberg A; Montaner JS
J Clin Densitom; 2010; 13(4):456-61. PubMed ID: 20663695
[TBL] [Abstract][Full Text] [Related]
15. Evolution of bone mineral density in AIDS patients on treatment with zidovudine/lamivudine plus abacavir or lopinavir/ritonavir.
Rivas P; Górgolas M; García-Delgado R; Díaz-Curiel M; Goyenechea A; Fernández-Guerrero ML
HIV Med; 2008 Feb; 9(2):89-95. PubMed ID: 18093130
[TBL] [Abstract][Full Text] [Related]
16. Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients.
Fernández-Rivera J; García R; Lozano F; Macías J; García-García JA; Mira JA; Corzo JE; Gómez-Mateos J; Rueda A; Sánchez-Burson J; Pineda JA
HIV Clin Trials; 2003; 4(5):337-46. PubMed ID: 14583850
[TBL] [Abstract][Full Text] [Related]
17. Identification of rheumatoid arthritis patients with vertebral fractures using bone mineral density and trabecular bone score.
Bréban S; Briot K; Kolta S; Paternotte S; Ghazi M; Fechtenbaum J; Roux C
J Clin Densitom; 2012; 15(3):260-6. PubMed ID: 22445857
[TBL] [Abstract][Full Text] [Related]
18. CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years.
Kwak MK; Lee EJ; Park JW; Park SY; Kim B-; Kim TH; Suh K; Koh J-; Lee SH; Byun D-
Osteoporos Int; 2019 Jul; 30(7):1501-1510. PubMed ID: 30915506
[TBL] [Abstract][Full Text] [Related]
19. Screening for osteoporosis using easily obtainable biometrical data: diagnostic accuracy of measured, self-reported and recalled BMI, and related costs of bone mineral density measurements.
van der Voort DJ; Brandon S; Dinant GJ; van Wersch JW
Osteoporos Int; 2000; 11(3):233-9. PubMed ID: 10824239
[TBL] [Abstract][Full Text] [Related]
20. Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors.
Shaiykova A; Pasquet A; Goujard C; Lion G; Durand E; Bayan T; Lachâtre M; Choisy P; Ajana F; Bourdic K; Viget N; Riff B; Quertainmont Y; Cortet B; Boufassa F; Chéret A
AIDS; 2018 Nov; 32(18):2689-2696. PubMed ID: 30234605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
